Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 18 or older
• People who have been diagnosed with metastatic triple-negative breast cancer, confirmed by a tissue test (this means the cancer tests negative for oestrogen receptors, progesterone receptors, and HER2)
• People whose doctor estimates they have a life expectancy of more than 6 months
• People who are about to start their first treatment for metastatic breast cancer (using an approved, marketed therapy)
• People whose general physical functioning is rated at a certain level by their doctor, known as ECOG performance status of 2 or below (confirm with trial site)
• People who have completed specific quality-of-life questionnaires (called EORTC QLQ-C30 and EORTC QLQ-BR45) at the start of the study, including two particular questions
• People who are covered by a social security or equivalent health insurance system
• People who are willing and able to fill in regular online self-reported questionnaires throughout the study, across multiple treatment stages
• People who have access to a computer, tablet, or smartphone with an internet connection
• People who have signed a written consent form before joining the study (if physically unable to sign, a trusted representative — not the investigator or study sponsor — may sign on their behalf)

Who may not be able to join:

• People who are already participating in another clinical trial that uses remote digital health monitoring
• People whose doctor determines they are physically or psychologically unable to use the digital monitoring app used in this study (called Cureety Techcare)
• People who are currently under a legal protective arrangement, such as guardianship or protective custody, or who are detained

Important: Always verify eligibility with the trial site directly before applying.